INO-9112

BIOLOGICAL2 trials

Sponsors

Inovio Pharmaceuticals

Conditions

Coronavirus InfectionHepatitis B

Phase 1

Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects

CompletedNCT02431312

Inovio PharmaceuticalsHepatitis B

Start: 2015-01-12End: 2018-05-22Updated: 2019-10-15

Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers

WithdrawnNCT05430958

Inovio PharmaceuticalsCoronavirus Infection

Start: 2022-10-31End: 2024-03-31Updated: 2022-11-17